Natixis’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-500,000
| Closed | -$600K | – | 1282 |
|
|
2022
Q3 | $600K | Buy |
+500,000
| New | +$600K | ﹤0.01% | 818 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$223K | – | 1393 |
|
|
2021
Q3 | $223K | Sell |
50,000
-60,700
| -55% | -$271K | ﹤0.01% | 1136 |
|
|
2021
Q2 | $642K | Buy |
+110,700
| New | +$642K | ﹤0.01% | 673 |
|
|
2021
Q1 | – | Sell |
-20,196
| Closed | -$97K | – | 1216 |
|
|
2020
Q4 | $97K | Sell |
20,196
-1,069,240
| -98% | -$5.14M | ﹤0.01% | 1016 |
|
|
2020
Q3 | $6.35M | Buy |
+1,089,436
| New | +$6.35M | 0.05% | 238 |
|
|
2018
Q2 | – | Sell |
-7,459
| Closed | -$394K | – | 1016 |
|
|
2018
Q1 | $394K | Buy |
+7,459
| New | +$394K | ﹤0.01% | 696 |
|
|
2017
Q4 | – | Sell |
-3,426
| Closed | -$282K | – | 1251 |
|
|
2017
Q3 | $282K | Buy |
+3,426
| New | +$282K | ﹤0.01% | 942 |
|